City

Aarau (1)

Basel (1)

Beijing (1)

Bern (1)

Zurich (1)

Condition

Detection Accuracy (2)

Cancer Screening (1)

Cervical Cancer (1)

Cervical Intraepithelial Neoplasia (1)

DNA Methylation (1)

Patient Compliance (1)

Overall Status

Completed (1)

Recruiting (1)

Phase

phase 2 (1)

Sponsor

Novartis Pharmaceuticals (1)

Peking Union Medical College Hospital (1)

Collaborator

Proteus Digital Health, Inc. (1)

Quintiles, Inc. (1)

Second Affiliated Hospital, School of Medicine, Zhejiang University (1)

Zhejiang Provincial People's Hospital (1)

Intervention

dna methylation testing (1)

ecmps-iem (1)

Study Documents

Intervention Type

diagnostic test (1)

drug (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (1)

Observational (1)

detection accuracy

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

DNA PAX1 and JAM3 Methylation for Cervical Cancer Screening

Recruiting

Cervical Cancer
+4 more

DNA methylation testing

Beijing, Beijing, China

Lei Li

Mar 12, 2022

Detection Accuracy, Patient Compliance Trial in Switzerland (ECMPS-IEM)

Completed

Detection Accuracy
Patient Compliance

ECMPS-IEM

Aarau, Switzerland
+4 more

Feb 20, 2017